/stocks — the workspaceLOADING
All ETRASEC filings, by type → · Earnings date & implied move · Search inside filings
Electra Therapeutics, Inc. (ETRA) is a biological products, (no diagnostic substances) company. Fundamentals from SEC filings; prices are end-of-day.
What’s behind ETRA’s latest move — the size, how unusual the volume is, and the catalyst on the tape, explained and cited to the source.
XBRL company facts, SEC EDGAR. TTM = last four reported quarters. Valuation ratios arrive with a price source — we don't fake quotes.
No recent 10-K / 10-Q / 8-K filings found.
Has ETRA been issuing shares? Offering history →
Not reported in XBRL for this filer.
Not reported in XBRL for this filer.
Not reported in XBRL for this filer.
↓ Download the fiscal-year statement table (XLSX) · revenue, income, EPS, cash flow, balance sheet · from SEC XBRL, dated
A plain-English read on ETRA plus an auto-SWOT — built from ETRA's SEC filings and market data, every point cited, nothing invented. Educational, not investment advice.
Four AI analysts — a bull, a bear, a risk manager, and a PM — debate ETRA using only the SEC-filing and market facts below. Every point cites its evidence; nothing is invented. This is educational research, not investment advice.
Educational only — not financial advice. Data from SEC EDGAR public filings; no live market data is shown. Figures reflect the company's own reported XBRL facts and may lag.
Projected from ETRA's own SEC 8-K filing history — the year-over-year reporting pattern (about 47% land the exact day, about 91% within a week, measured across 4,713 past reports). No analyst estimates and nothing invented, and every confirmed date links to the source it came from, so you can check it yourself. It upgrades the momentETRA files or announces.
Earnings dates are the company's 8-K Item 2.02 filings (SEC). Reactions from Databento EOD.
No open-market Form 4 buys or sells reported for ETRA in the last ~6 months.
No lawmaker has disclosed a trade in ETRA under the STOCK Act.
No tracked institution reported a position in ETRA in the latest 13F round.